• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

Media Coverage

August 28, 2016

Infused stem cells in heart failure: Improved health status but not cardiac function

News Aug 28, 2016 Infused stem cells in heart failure: Improved health status but not cardiac function A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or

Read More

Media Coverage,  News

August 28, 2016

CardioCell To Pursue Large-Scale Chronic Heart Failure Trial For IV Stem Cell Therapy

News Aug 28, 2016 CardioCell To Pursue Large-Scale Chronic Heart Failure Trial For IV Stem Cell Therapy CardioCell has presented data from the first clinical trial to demonstrate the safety and viability of intravenous (IV) ischemia-tolerant mesenchymal stem cells in chronic heart

Read More

Media Coverage,  News

August 28, 2016

Studies Explore Safety and Efficacy of Stem Cell Therapies

News Aug 28, 2016 Studies Explore Safety and Efficacy of Stem Cell Therapies Safety and efficacy of stem cell therapies were explored in two separate trials presented on Aug. 28 during ESC Congress 2016 in Rome. ... Meanwhile, a single dose of mesenchymal stem cells delivered

Read More

Media Coverage,  News

June 15, 2016

European Society of Cardiology Selects CardioCell’s Heart Failure (HF) Study Results For ESC Congress 2016 Late-Breaking Science Session

News Jun 15, 2016 European Society of Cardiology Selects CardioCell's Heart Failure (HF) Study Results For ESC Congress 2016 Late-Breaking Science Session CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announces that the

Read More

Media Coverage,  News

April 21, 2016

CardioCell in talks with investment banks for Series B; will seek global CRO by late 2016

News Apr 21, 2016 CardioCell in talks with investment banks for Series B; will seek global CRO by late 2016 CardioCell is in talks with investment banks for a Series B raise in a hopefully relatively short period of time, said CEO Sergey Sikora. The funding will go toward the

Read More

Media Coverage,  News

April 19, 2016

CardioCell Completes Enrollment For A Phase IIa Clinical Trial Using Its Stem Cells For Participants With Chronic Heart Failure

News Apr 19, 2016 CardioCell Completes Enrollment For A Phase IIa Clinical Trial Using Its Stem Cells For Participants With Chronic Heart Failure CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, fulfills enrollment for its

Read More

Media Coverage,  News

March 22, 2016

CardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center

News Mar 22, 2016 CardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, welcomes MedStar Washington Hospital

Read More

Media Coverage

January 6, 2016

Clinical Trial Will Study Novel Stem Cells in Cardiac Patients

News Jan 6, 2016 Clinical Trial Will Study Novel Stem Cells in Cardiac Patients When stem cell research targeted to cardiovascular disease first made headlines almost two decades ago, many speculated it would create a new era of medical therapy for acute myocardial infarction and

Read More

Media Coverage,  News

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • …
  • Page 7
  • Next Page »

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in